In today’s recent session, 0.51 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) have been traded, and its beta is -0.75. Most recently the company’s share price was $11.47, and it changed around $0.77 or 7.24% from the last close, which brings the market valuation of the company to $336.77M. CADL at last check was trading at a discount to its 52-week high of $11.40, offering almost 0.61% off that amount. The share price’s 52-week low was $0.66, which indicates that the recent value has risen by an impressive 94.25% since then. We note from Candel Therapeutics Inc’s average daily trading volume that its 3-month average coming to 5.53 million.
Candel Therapeutics Inc (NASDAQ:CADL) trade information
Instantly CADL has been showing a green trend so far today with a performance of 7.24% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently up 680.56% year-to-date, but still up 5.95% over the last five days. On the other hand, Candel Therapeutics Inc (NASDAQ:CADL) is 94.81% up in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Candel Therapeutics Inc (CADL) estimates and forecasts
Candel Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 1161.46 percent over the past six months and at a 30.53% annual growth rate that is well above the industry average of 13.10%.
The company’s sales for the same quarters a year ago were -$.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -46.75%.
